It would nice to know who the international investors are? Big names?
The Placement was well supported, closing early with a scaled acceptance from existing
and new Australian and international investors. At $0.26 cents per share, the Placement
sees an 85% premium to the Company’s February capital raise, when priced at a 17.5 per
Recce Chairman Dr John Prendergast said: “We are delighted by the strong support from
existing holders and welcome our new shareholders. Demand significantly exceeded the
capital raised with our business now well-funded to progress the Company’s clinical
programs and global commercialisation strategy.
RCE Technicals - Breaking upwards following small period of consolidation, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.005(1.67%) |
Mkt cap ! $87.95M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 29.0¢ | $40.61K | 136.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11547 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |